Global Leukemia Therapeutics 2019 To 2025

Size Study, by type (Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia), by application (Chemotherapy, Radiation Therapy, Targeted Therapy, Biological Therapy, Stem Cell Transplant) and Regional Forecasts

Published	Pages	Publisher	Report code
Oct 2020	200	Bizwit Research	ASDR-564573

Published: Oct 2020 - Pages : 200 - Publisher : Bizwit Research - Report code : ASDR-564573

Biogen
GSK
Novartis AG
Pfizer
Roche
Takeda Oncology
Teva Pharmaceutical
Celgene
Daiichi Sankyo
EISAI Co. Ltd.